Dexamethasone: Difference between revisions
| Line 138: | Line 138: | ||
Dexamethasone is readily absorbed from the gastrointestinal tract. | Dexamethasone is readily absorbed from the gastrointestinal tract. | ||
Plasma half-life is about 190 minutes. | Plasma half-life is about 190 minutes. | ||
Binding of dexamethasone to plasma proteins is about 77%. | Binding of dexamethasone to plasma proteins is about 77%. | ||
Up to 65% of a dose is excreted in urine within 24 hours. | Up to 65% of a dose is excreted in urine within 24 hours. | ||
Revision as of 02:31, 5 October 2020
Pronunciation
Dexamethasone 0.5mg
Introduction
Dexamethasone is a steroid with anti-inflammatory and immunosuppressant effects. It is used to treat a wide range of inflammatory and autoimmune conditions.
Indications include:
- Inflammatory bowel disease
- Asthma
- Croup in children
- dermatitis
- Rheumatoid arthritis
- Cerebral oedema associated with malignancy
- Counteract nausea and vomiting effects of cancer chemotherapy
- Administered before antibiotics in cases of baceterial meningitis. It reduces the inflammatory response, thus reducing hearing loss and neurological damage.
- High-attitude cerebral edema (HACE) and high-attitude pulmonary edema (HAPE), help climbers to cope with complications of high-attitude sickness
Equivalent anti-inflammatory doses of steroids
| Prednisolone 5 mg is equivalent to | Betamethasone 750 micrograms |
|---|---|
| dexamethasone 750 micrograms | |
| hydrocortisone 20 mg | |
| methylprednisolone 4 mg | |
| triamcinolone 4 mg |
Mechanism of Action
Immunosuppression agent, Steroid replacement agent, Anti-inflammatory agent
| Generic Name
藥名 |
HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Dexamethasone Tablet 0.5 mg | DEXA01 | P1S1S3 |
| Dexamethasone Tablet 4 mg | DEXA19 | P1S1S3 |
| Dexamethasone 0.1% + Chloramphenicol 0.5% Eye Drops 5ml | DEXA16 | P1S1S3 |
| Dexamethasone 0.1% + Neomycin 0.5% Eye Drops 10ml | DEXA04 | P1S1S3 |
Dosage
Dosages of steroids vary widely in different diseases and in different patients.
When long-term steroid therapy is used in some chronic diseases, the adverse effects of treatment may be great. To minimize side-effects the maintenance dose should be kept as low as possible.
Steroids are used both topically (by rectum or eye) and systemically (by mouth or intravenously).
Whenever possible local treatment with creams, intra-articular injections, inhalations, eye-drops or enemas should be used in preference to systemic treatment.
The suppressive action of a steroid on cortisol secretion is least when it is given as a single dose in the morning.
Oral: usual range 0.5 – 5 mg daily
Child dose: 10-100 micrograms/kg daily
Cerebral oedema, by intravenous injection: 8-16 mg initially, then 5 mg by intramuscular or intravenous injection every 6 hours until the symptoms of edema subside for 2-4 days, then gradually reduced and stopped over 5-7 days.
By intra-articular injection, 0.8 – 4mg of dexamethasone (as sodium phosphate) are used depending upon the size of the joint.
For soft-tissue injection, 2 – 6 mg are used.
For topical application in various skin disorders, concentrations of dexamethasone in the range of 0.02 to 0.1% is used in creams, ointments and lotions. Whereas for eye or ear preparations, concentrations are commonly 0.05 to 0.1%.
Side Effects
Short-term use include nausea and feeling tired. More severe side effects include psychiatric problems including euphoria, nightmares, insomnia, irritability, confusion, suicidal thoughts and behavioral disturbances. This may occur in about 5% of people.
| Adrenal suppression | |
|---|---|
| Steroid-induced diabetes | |
| Osteoporosis, muscle wasting and weakness | which is a danger, particularly in the elderly, as it can result in osteoporotic fractures for example of the hip or vertebrae |
| Susceptibility to infection | |
| Cushing’s syndrome | moon face, striae, and acne |
| Endocrine side effects | menstrual irregularities and amenorrhea, hirsutism, weight gain, hyperlipidemia |
| Neuropsychiatric side effects | aggravation of schizophrenia, aggravation of epilepsy, insomnia, irritability, mood changes |
| Dermatological effects | easy bruising, impaired wound healing, and thinning of skin |
| Ophthalmic effects | glaucoma, corneal or scleral thinning and exacerbation of ophthalmic viral or fungal disease |
Side-effects can be minimized by using lowest effective dose for minimum period possible.
Pharmacokinetics
Dexamethasone is readily absorbed from the gastrointestinal tract.
Plasma half-life is about 190 minutes.
Binding of dexamethasone to plasma proteins is about 77%.
Up to 65% of a dose is excreted in urine within 24 hours.
